BRILINTA FDA approval: A major step in reducing stroke risks in acute ischemic stroke and high-risk TIA patients

AstraZeneca has secured U.S. Food and Drug Administration (FDA) approval for BRILINTA (ticagrelor), expanding its use to reduce the risk of stroke in patients suffering ... Read More